[ad_1]
A new study published in the Lancet, used malaria mapping techniques to examine access to treatment, the availability of anti-venom drugs, and the frequency of life of the human population and patients. venomous species of the snake [19659002] Of the 278 venomous snake species, there is no specific anti-venom treatment for 119. Of these species, 24 are clbadified by the WHO as "category 1" , that is, the most widespread and the most deadly. And 95 are second-clbad species, less common and deadly.
The researchers then ranked 93 million people worldwide as being vulnerable to snake bite, ie sharing their habitat with one or more deadly snakes. anti venom, they live at three or more hours in an urban center of at least 50,000 people and available health care is clbadified as poor quality.
Taking all these factors into account, the researchers found that Ethiopia, Myanmar, Nigeria, Papua New Guinea and South Sudan are the most likely to die or d? be severely disabled after a snake bite.
For example, in Papua New Guinea, over 600,000 people In contrast, in the UK, there is a species of snake category 1 – the adder – but because it There are several anti-venom drugs available and the majority of the population Within an hour of a health facility, the risk to the population is low.
[ad_2]
Source link
